ABSTRACT
Understanding the factors driving acute exacerbations of COPD is key to reducing their impact on human health and wellbeing. 5997 patients, mean 66 years, 64% female, completed an online survey between December 2020 and May 2021 about living with COPD developed by the charity Asthma+Lung UK. The 3731(62.2%) reporting frequent(≥2/year) exacerbations were more likely to smoke (AOR 1.70, 95%CI 1.470-1.98), have lower annual household income (≤£20,000, (AOR: 1.72, 1.36-2.17), live in a cold and damp home (AOR: 1.78, 1.50-2.11), and report previous occupational exposure to dust, fumes, and chemicals. Strategies to improve COPD outcomes must address issues of social justice.
Competing Interest Statement
Conflicts of interest; NSH is Chair of Action on Smoking and Health and Medical Director of The British Lung Foundation. AAL is a Trustee of Action on Smoking and Health. Other authors have no conflict of interest to declare.
Clinical Trial
ISRCTN12455871
Funding Statement
PW is funded by RM Partners, West London Cancer Alliance, hosted by The Royal Marsden NHS Foundation Trust. The funders had no input into data analysis or the writing of this manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee Imperial College Research Governance Integrity team Research Governance and Integrity Team of Imperial College London gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflicts of interest; NSH is Chair of Action on Smoking and Health and Medical Director of The British Lung Foundation. AAL is a Trustee of Action on Smoking and Health. Other authors have no conflict of interest to declare.
Data Availability
Anonymised research data will be shared with third parties via request to Asthma + Lung UK.
